The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID)

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1245, 2000-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content